Replies to post #203745 on Biotech Values

[lgonber]

CRISPR tech: here an interesting article on the IP situation from a lawyer perspective:
http://www.biochemist.org/bio/03803/0026/038030026.pdf

[DewDiligence]

AMRI taken private by Carlyle/GTCR for $21.75/sh in cash—a 52% premium to the closing price on 4/7/16, when AMRI disclosed that it was in play:

https://finance.yahoo.com/news/amri-signs-definitive-agreement-acquired-113000219.html

AMRI shareholders will vote on the deal, but it appears to be a fait accompli. The nominal deal value is $922M.